Adagio Medical Holdings, Inc ADGM 深 沪
等待开盘 07-24 09:30:00 美东时间
0.49
+0.023
+4.93%
华盛通- 最 高0.536
- 今 开0.488
- 成交量 4.03万股
- 最 低 0.47
- 昨 收 0.467
- 总市值 1088.31万
- 52周最高 2.582
- 市盈率 静 --
- 换手率 0.18%
- 52周最低 0.44
- 委 比 77.80%
- 总股本 2221.05万
- 历史最高 9.34
- 量 比 0.53
- 振 幅 14.13%
- 历史最低 0.44
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
LUCID CAPITAL MARKETS Initiates Coverage On Adagio Medical Holdings with Buy Rating, Announces Price Target of $3
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $3.
06-04 01:52
Adagio Medical Submits PMA Application To FDA For vCLAS Ventricular Ablation System For Treatment Of Drug-Refractory, Recurrent, Sustained Monomorphic VT In Patients With Ischemic Or Non-Ischemic Structural Heart Disease
PMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously GrantedMarks the First-Ever PMA Submission for a Purpose-Built VT Ablation
05-21 20:05
Adagio Medical Holdings Q1 EPS $(0.31) Misses $(0.29) Estimate
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 39.22 percent increase over losses of $(0.51) per
05-12 20:11
Adagio Medical Heart Ablation System Shows 84% Freedom From Shock
Adagio Medical shares rise after vCLAS trial shows strong VT outcomes, reduced drug use, and lower readmissions ahead of FDA review.
04-27 19:55
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
04-16 01:53
美股大行评级 | 小摩上调Bloom Energy目标价从166美元升至231美元；目标价28美元！大摩、高盛等多家机构首予Janus Living(JAN)超配评级
今日重点评级关注：Ascendiant Capital：维持Banzai International"买入"评级，目标价从23美元升至24美元；Ascendiant Capital：维持Synergy CHC Corp."买入"评级，目标价从5美元升至5.5美元
04-15 11:31
Adagio Medical's FULCRUM-VT Trial Receives FDA's Investigational Device Exemption Approval To Evaluate Safety, Effectiveness Of vCLAS Ultra-Low Temperature Ablation Ventricular Ablation System To Treat Sustained Monomorphic Ventricular Tachycardia
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug
04-08 20:08
Adagio Medical Holdings Q4 EPS $(0.21) Beats $(0.31) Estimate
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.31) by 32.26 percent. This is a 94.29 percent increase over losses of $(3.68) per
03-27 20:25
Adagio Medical Holdings Announces Publication Of Pre-Clinical Results Of Next-Gen Ultra-Low Temperature Ablation Technology To Treat Ventricular Arrhythmias
Highlights Improvements in Next Generation ULTA Catheter, Including Potential 50-75% Reduction in Ablation TimeAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter
03-24 20:09
